HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-08-28FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Tybost (cobicistat) submitted by Gilead Sciences, Inc., indicating an update to the product labe…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies [NA]
This clinical trial update reports completion of a study evaluating micronutrient-supplemented probiotic yogurt in people with HIV infection…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Culturally Congruent HIV Risk Reduction App for Young Women, an Acceptability & Pilot Evaluation [NA]
A completed pilot study evaluating the acceptability and preliminary outcomes of a culturally tailored HIV risk-reduction app for young wome…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Evaluate the Safety & Assess Local and Systemic PK of DS003 Vaginal Tablets Administered to Healthy HIV-negative Women [Phase 1]
Phase 1 trial updates safety and pharmacokinetics of DS003 vaginal tablets in healthy HIV-negative women; study status completed.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Nutritional Therapy Improves Dyslipidemia in HIV Infected Teenagers With Antiretroviral Treatment [NA]
A completed clinical trial found that nutritional therapy improves dyslipidemia in HIV-infected teenagers on antiretroviral therapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Monitoring Liver Disease Progression in Hepatitis C/HIV Co-infected Patients With No-to-moderate Fibrosis, in Phnom Penh, Cambodia
A clinical trial assessing liver disease progression in Hepatitis C and HIV co-infected patients with no-to-moderate fibrosis in Phnom Penh …
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Evaluation of Raltegravir During the Third Trimester of Pregnancy [Phase 2]
Phase 2 trial evaluating raltegravir during the third trimester of pregnancy.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol) [Phase 2]
Phase 2 trial evaluating maintenance therapy with lamivudine and dolutegravir in HIV-1 infected patients virologically suppressed on triple …
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Effect of Supplementation With Glutamine and Exercise in Women With HIV/AIDS [NA]
This completed trial evaluated the effects of glutamine supplementation combined with exercise in women with HIV/AIDS.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients [Phase 4]
A Phase 4 epidemiological study completed, evaluating the prevalence of the HLA-B*57:01 allele in HIV-1 infected patients.
-
CLINICAL_TRIALS research · 2017-08-22Clinical Trial Update: Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002
An observational follow-up study is being conducted for patients previously enrolled in the ISS T-002 therapeutic trial for HIV infection.
-
FDA approval · 2017-08-21FDA Approved: ODEFSEY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for ODEFSEY (emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide) submitted by G…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Measurement of Plasma and Intracellular Concentrations of Raltegravir [NA]
A completed clinical trial evaluating pharmacokinetics by measuring plasma and intracellular concentrations of raltegravir in HIV patients. …
-
CLINICAL_TRIALS research · 2017-08-18Clinical Trial Update: PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation
A clinical trial update for the PrEP Impact Trial evaluating PrEP implementation and health technology assessment; the trial status is unkno…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects [Phase 1]
Phase 1 study characterizes the pharmacokinetics of aprepitant in HIV-infected subjects and explores potential anti-inflammatory effects.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Management and Optimization of Nutrition, Antenatal, Reproductive, Child Health & HIV Care [NA]
A completed clinical trial sponsored by the University of KwaZulu evaluated integrated management and optimization of nutrition, antenatal c…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Integrating HIV and Hepatitis C Screening in an Urban Emergency Department [NA]
Clinical trial evaluating integrating HIV and Hepatitis C screening in an urban emergency department. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Transplantation and the Use of Raltegravir in HIV-Infected Patients
Clinical trial completion update on the use of raltegravir in HIV-infected patients undergoing organ transplantation. The trial was sponsore…
-
FDA approval · 2017-08-15FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for GENVOYA (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) from Gilead Science…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating Carraguard vaginal gel to prevent HIV transmission.
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use [Phase 1]
A Phase 1 trial completed to evaluate the safety, pharmacokinetics, and acceptability of vaginally administered PC-1005 for HIV prevention.
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women [Phase 1]
Phase 1 randomized cross-over study assessing the safety of vaginal Carraguard gel in HIV-infected women has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide [Phase 2]
Phase 2 trial assessing PC-515 as a vaginal microbicide reports safety, acceptability, and preliminary effectiveness data.
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study [Phase 4]
Phase 4 pilot trial evaluating dolutegravir/lamivudine dual therapy in ART-naive HIV-1 infected individuals has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand [Phase 1]
Phase 1 study evaluating the safety and acceptability of Carraguard, a carrageenan-based vaginal microbicide gel, among HIV-negative couples…